© 2022 BioMarin. All rights reserved.

Marcia Kayath, M.D., Ph.D., M.B.A., joined BioMarin in October 2022 and currently serves as Senior Vice President and Head of Global Medical Affairs.

Prior to joining BioMarin, Dr. Kayath was the Chief Medical Officer and Global Medical Affairs Head at Novartis. There, she held roles in multiple therapeutic areas, within Development and Medical Affairs, with oversight of the USA (US-based) and Global (Switzerland-based) regions. Prior to joining Novartis, Dr. Kayath held roles within clinical research at Eli Lilly and at Pfizer.

Dr. Kayath earned an MD degree from Federal University of Rio de Janeiro and completed residency in Endocrinology and a Ph.D. in endocrine bone metabolism diseases at Federal University of São Paulo. Dr. Kayath holds a postdoctoral degree focused on cartilage metabolism from University of California San Francisco. She practiced as an endocrinologist for many years prior to joining the biotechnology industry, where her focus is on continuing to improve patient outcomes in partnership with healthcare systems.


Our Pipeline

We maximize the impact of genetic innovation to develop transformative therapies.

Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.

View Now Our Pipeline